Efficacy and Safety of Gilteritinib versus Sorafenib as Post-Transplant Maintenance in Patients With FLT3-ITD Acute Myeloid Leukemia.
Yeh J, Pasvolsky O, Saliba RM, Figgins B, Wang C, Fang Z, Ahmed S, Yilmaz M, Daver N, Ravandi F, DiNardo C, Short NJ, Kadia T, Al-Atrash G, Daher M, Costa DM, Popat U, Champlin R, Shpall E, Oran B.
Yeh J, et al. Among authors: figgins b.
Clin Lymphoma Myeloma Leuk. 2024 Nov;24(11):e819-e826. doi: 10.1016/j.clml.2024.07.001. Epub 2024 Jul 25.
Clin Lymphoma Myeloma Leuk. 2024.
PMID: 39183099